NASDAQ: SION
Sionna Therapeutics Inc Stock Ownership - Who owns Sionna Therapeutics?

Insider buying vs selling

Have Sionna Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter A. ThompsonDirector2026-05-27101$44.49
$4.49kSell
Orbimed Advisors LLCDirector2026-05-27101$44.49
$4.49kSell
Orbimed Advisors LLCDirector2026-05-11184,639$46.22
$8.53MSell
Peter A. ThompsonDirector2026-05-11184,639$46.22
$8.53MSell
Peter A. ThompsonDirector2026-05-0859,767$44.58
$2.66MSell
Orbimed Advisors LLCDirector2026-05-0859,767$44.58
$2.66MSell
Peter A. ThompsonDirector2026-05-0748,546$44.61
$2.17MSell
Orbimed Advisors LLCDirector2026-05-0748,546$44.61
$2.17MSell
Peter A. ThompsonDirector2026-04-182,948$44.52
$131.24kSell
Orbimed Advisors LLCDirector2026-04-182,948$44.52
$131.24kSell

1 of 17

SION insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SION insiders and whales buy or sell their stock.

SION Shareholders

What type of owners hold Sionna Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP21.94%9,905,045$363.81MInstitution
Tpg GP A LLC14.39%6,494,962$238.56MInstitution
Tpg GP A LLC14.39%6,494,962$238.56MInsider
Peter A. Thompson14.12%6,376,680$234.22MInsider
Atlas Venture Fund XI LP8.18%3,694,020$135.68MInsider
Orbimed Advisors LLC7.82%3,530,702$129.68MInstitution
Viking Global Investors LP7.08%3,195,181$117.36MInstitution
Bruce Booth6.63%2,995,602$110.03MInsider
Atlas Venture Life Science Advisors LLC6.63%2,995,602$110.03MInstitution
Orbimed Advisors LLC5.92%2,671,721$98.13MInsider

1 of 3

SION vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SION66.37%33.63%Net SellingNet Selling
TYRA65.84%34.16%Net SellingNet Selling
SNDX91.45%8.55%Net SellingNet Selling
ABCL40.70%44.12%Net BuyingNet Buying
ZYME51.34%48.66%Net Buying

Sionna Therapeutics Stock Ownership FAQ

Who owns Sionna Therapeutics?

Sionna Therapeutics (NASDAQ: SION) is owned by 100.57% institutional shareholders, 50.95% Sionna Therapeutics insiders, and 0.00% retail investors. Tpg GP A LLC is the largest individual Sionna Therapeutics shareholder, owning 6.49M shares representing 14.39% of the company. Tpg GP A LLC's Sionna Therapeutics shares are currently valued at $242.26M.

If you're new to stock investing, here's how to buy Sionna Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.